Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
SNN | US
-0.35
-1.10%
Healthcare
Medical Devices
30/06/2024
24/04/2026
31.57
31.45
31.58
31.26
Smith & Nephew plc together with its subsidiaries develops manufactures markets and sells medical devices and services in the United Kingdom and internationally. The company operates through three segments: Orthopaedics Sports Medicine & ENT and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products including instruments technologies and implants to perform minimally invasive surgery of the joints such as the repair of soft tissue injuries and degenerative conditions of the shoulder knee hip and small joints. In addition the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access high-definition cameras digital image capture scopes light sources and monitors to assist with visualization inside the joints radio frequency electromechanical and mechanical tissue resection devices and hand instruments for removing damaged tissue; and ear nose and throat solutions. Further it provides advanced wound care products for the treatment and prevention of acute and chronic wounds which comprise leg wounds diabetic and pressure ulcers burns and post-operative wounds; advanced wound bioactives such as biologics and other bioactive technologies for debridement and dermal repair/regeneration as well as regenerative medicine products including skin bone graft and articular cartilage substitutes; and advanced wound devices such as traditional and single-use negative pressure wound therapy and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford the United Kingdom.
View LessLow 6-Month Volatility (<30%)
Largecap (10B - 200B USD)
Good Dividend Yield (2% <= Dividend Yield <= 8%)
Low Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High Short-term Volatility
Weak P/E, and PEG ratio indicator
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
27.6%1 month
27.2%3 months
24.5%6 months
28.7%42.23
11.93
2.46
0.70
0.35
15.89
2.80
0.44
1.08B
13.76B
13.76B
2.54
11.60
24.40
3.40
5.84
5.03
0.16
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
3.45
Range1M
3.50
Range3M
5.88
Rel. volume
1.36
Price X volume
38.87M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Align Technology Inc | ALGN | Medical Devices | 189.61 | 14.16B | -0.56% | 37.24 | 3.44% |
| Insulet Corporation | PODD | Medical Devices | 189.56 | 13.29B | -1.38% | 42.71 | 140.00% |
| Globus Medical Inc | GMED | Medical Devices | 94.87 | 12.85B | 0.52% | 364.25 | 13.35% |
| The Cooper Companies Inc | COO | Medical Instruments & Supplies | 64.42 | 12.83B | -0.82% | 60.14 | 33.22% |
| Penumbra Inc | PEN | Medical Devices | 329.89 | 12.81B | -0.93% | 596.14 | 19.70% |
| Masimo Corporation | MASI | Medical Instruments & Supplies | 178.63 | 9.55B | -0.04% | 98.41 | 63.08% |
| Baxter International Inc | BAX | Medical Instruments & Supplies | 18.16 | 9.26B | -1.36% | n/a | 174.58% |
| Glaukos Corporation | GKOS | Medical Instruments & Supplies | 121.48 | 6.68B | 0.50% | n/a | 23.55% |
| Teleflex Incorporated | TFX | Medical Instruments & Supplies | 136.56 | 6.43B | -0.07% | 42.85 | 39.94% |
| BLCO | BLCO | Medical Instruments & Supplies | 15.82 | 5.57B | 0.25% | n/a | 71.22% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| CoStar Group Inc | CSGP | Real Estate Services | 36.44 | 14.93B | -2.51% | 152.40 | 14.68% |
| Avery Dennison Corporation | AVY | Building Products & Equipment | 165.5 | 13.33B | -1.15% | 27.93 | 140.74% |
| Zillow Group Inc | ZG | Real Estate Services | 45.63 | 10.91B | 2.54% | n/a | 40.19% |
| Brookfield Property Partners L.P | BPYPP | Real Estate Services | 16.25 | 10.74B | -1.12% | 7.95 | 866.10% |
| Zillow Group Inc | Z | Real Estate Services | 45.41 | 10.51B | 2.04% | n/a | 40.19% |
| Sirius XM Holdings Inc | SIRI | Broadcasting - Radio | 26.61 | 9.02B | -4.96% | 8.37 | -444.39% |
| FirstService Corporation | FSV | Real Estate Services | 146.38 | 6.59B | -1.86% | 103.88 | 145.73% |
| Colliers International Group Inc | CIGI | Real Estate Services | 108.8 | 5.62B | -1.87% | 50.24 | 163.75% |
| FBIN | FBIN | Building Products & Equipment | 41.54 | 5.16B | 0.34% | 25.57 | 130.24% |
| Newmark Group Inc | NMRK | Real Estate Services | 16.04 | 3.97B | 0.06% | 59.40 | 179.32% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 15.89 | 46.09 | Cheaper |
| Ent. to Revenue | 2.80 | 14.34 | Cheaper |
| PE Ratio | 42.23 | 30.41 | Expensive |
| Price to Book | 2.46 | 6.21 | Cheaper |
| Dividend Yield | 2.54 | 1.78 | Leader |
| Std. Deviation (3M) | 24.53 | 64.12 | Lower Risk |
| Debt to Equity | 0.70 | -145.53 | Expensive |
| Debt to Assets | 0.35 | 0.35 | Par |
| Market Cap | 13.76B | 9.70B | Market Leader |